This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Wei Feng: Innovator in Cancer Treatment
Introduction
Wei Feng is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. With a total of 2 patents to his name, his work is recognized for its potential impact on therapeutic methods.
Latest Patents
Wei Feng's latest patents focus on Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer. The invention provides compounds of formula I, wherein A, B, X, and Y have any of the values defined in the specification. These compounds are part of pharmaceutical compositions that include processes for preparing such compounds and therapeutic methods for treating cancer and other topoisomerase mediated conditions.
Career Highlights
Wei Feng is affiliated with Rutgers, the State University of New Jersey, where he conducts his research. His work is characterized by a commitment to advancing medical science and improving treatment options for cancer patients.
Collaborations
Some of Wei Feng's coworkers include Edmond Joseph LaVoie and Leroy Fong Liu. Their collaborative efforts contribute to the innovative research environment at Rutgers.
Conclusion
Wei Feng's contributions to cancer treatment through his patented inventions highlight his role as a significant figure in the field of medical innovation. His work continues to pave the way for advancements in therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile